Results for tag: "Cefoxazole"

Cefoxazole is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of bacterial infections. Cefoxazole is used to treat infections caused by Gram-positive and Gram-negative bacteria, including skin and soft tissue infections, urinary tract infections, and respiratory tract infections. It is also used to treat certain sexually transmitted diseases. Cefoxazole is available in both oral and intravenous formulations. The cefoxazole market is driven by the increasing prevalence of bacterial infections, the growing demand for antibiotics, and the increasing availability of generic cefoxazole. The rising prevalence of antibiotic-resistant bacteria is also driving the market. The increasing prevalence of infectious diseases is also expected to drive the market. Some of the major companies in the cefoxazole market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Show Less Read more